M&A Deal Summary

Kubat Healthcare Acquires Hilltop Drugs

On May 9, 2022, Kubat Healthcare acquired life science company Hilltop Drugs

Acquisition Highlights
  • This is Kubat Healthcare’s 1st transaction in the Life Science sector.
  • This is Kubat Healthcare’s 1st transaction in the United States.
  • This is Kubat Healthcare’s 1st transaction in Nebraska.

M&A Deal Summary
Date 2022-05-09
Target Hilltop Drugs
Sector Life Science
Buyer(s) Kubat Healthcare
Deal Type Add-on Acquisition

Target

Hilltop Drugs

Neligh, Nebraska, United States
Hilltop Drugs is a community staple providing personalized pharmacy and healthcare services. Hilltop Drugs was founded in 2008 and is based in Neligh, Nebraska.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Kubat Healthcare

Omaha, Nebraska, United States
Category Company
Sector Healthcare Services
DESCRIPTION

Kubat Healthcare is a health care service provider that currently has three locations serving the Omaha metro. In addition, they expanded their services to Lincoln, Norfolk, Ashland, Beatrice, Louisville, Columbus, and Fremont. Kubat Healthcare is based in Omaha, Nebraska.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Nebraska) 1 of 1
Country (United States) 1 of 1
Year (2022) 1 of 1
Mergr

Product

Company

Legal